New study proved that women with Inflammatory Bowel Disease (IBD) did well during pregnancy, but they had higher rates of Caesarean section.
Immunosuppressive Therapy for IBD Does Not Increase Women's Risk of Vulvar or Vaginal Cancer
Immunosuppressive drugs are the cornerstone in the treatment of inflammatory bowel disease (IBD). However, they are linked to an increased risk of vulvar or vaginal cancer. Hence, a new study investigates the risk of these malignancies in IBD-patients.
Immunosuppressive drugs are the cornerstone in the treatment of inflammatory bowel disease (IBD). However, they are linked to an increased risk of vulvar or vaginal cancer. Hence, a new study investigates the risk of these malignancies in IBD-patients.
‘Pregnant women with mild to moderate IBD experience a higher rate of miscarriage and intrauterine growth retardation than women without IBD.’
Read More..
Overall, women with IBD did well during pregnancy; however, they had higher rates of Caesarean section and intrauterine growth retardation (low birth weight babies) than women without IBD.Read More..
Of the patients who had Crohn's disease, those with quiescent-to-mild disease did as well as women without IBD; however, women with Crohn's disease that was not mild-to-moderate had a higher rate of miscarriage and almost a 3-fold higher rate of intrauterine growth retardation than women without IBD.
"Previous studies could be easily biased since considerable numbers of pregnant women with IBD with quiescent or mild activity were likely to be excluded. We overcame this limitation by using a nationwide database covering 98% of the 52 million citizens of an entire nation," said corresponding author Bo-In Lee, MD, PhD, of The Catholic University of Korea.
Source-Eurekalert
